Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
about
Virulence factors in Escherichia coli urinary tract infectionEffect of salicylate, bismuth, osmolytes, and tetracycline resistance on expression of fimbriae by Escherichia coliP-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogensThermoregulation of the pap operon: evidence for the involvement of RimJ, the N-terminal acetylase of ribosomal protein S5Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cellsSynthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model.Waging war against uropathogenic Escherichia coli: winning back the urinary tractAdhesins as targets for vaccine development.Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged miceCellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccineCoordinate expression of fimbriae in uropathogenic Escherichia coliOsmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coliConstruction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infectionThe PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activityGal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.Administration in vivo of recombinant interleukin 2 protects mice against septic death.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli.Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coliIn vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infectionsChanging treatment patterns in urinary infectionsIn vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections.Binding of type 1-piliated Escherichia coli to vaginal mucus.Local cytokine production in a murine model of Escherichia coli pyelonephritisIn vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA.The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.Escherichia coli in extra-intestinal infections.Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic BacteriaPili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal piliGal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes.A block of urovirulence genes encoding multiple fimbriae and hemolysin in Escherichia coli O4:K12:H-Cell surface hydrophobicity, adherence to HeLa cell cultures and haemagglutination pattern of pyelonephritogenic Escherichia coli strains.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains.Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence.The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A.Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons.Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model
P2860
Q28468751-DC92B8D2-5A48-418D-8E2E-95ECAC16E5BCQ30451201-D5E45308-09E8-4B6E-BAC0-52C344CC0E1CQ30558351-CC967FF1-D720-4E80-99E3-B6FD2B24EF33Q31163628-C451CE11-2EDB-4FB2-9913-316270C049AAQ33424966-AC9010F1-4CA1-4187-B420-D968101997B3Q33554449-68657945-49F0-4C9C-B7BA-32A1CF198798Q33613902-64850F67-016C-4670-9A18-ABD61374561BQ33643106-770FF5C2-1334-4F8E-81AA-24B1F9CFF62EQ33755910-372523E1-F251-4AA1-A9FB-2FCC4BDC1C0EQ33850497-D823E485-0AD7-471A-96C5-286785E4B4C4Q34111922-55778970-E0A8-49E7-97F7-8C42B102BF4CQ34114951-DC59AD8C-8B4B-4914-8246-F08ED21922B7Q34533582-AAB057FA-AEF4-474D-BB4B-5BCB8DDFB56EQ34547122-5B6D1A52-D7EE-4FAA-A67C-A427D9D9CED8Q34575791-E13EA20F-C129-48C2-92F4-7ED8F37E58C3Q34576288-ADE3217D-2273-421A-8A51-38A16A41B096Q34641267-3B0F7031-6FF6-417C-918A-D65EEA0757A2Q34741586-AB43156E-7925-44D3-9E85-D929B625A576Q35008536-F8E93F5B-E8B4-42C6-8676-A5F41B65B9A3Q35089948-93D2D77F-3122-4502-A6B3-1EC8BF51A058Q35096528-75F655FE-5F0A-4D94-B7FA-8421E257E370Q35119835-D4CAC0B6-2F09-4D21-B3B6-9F23372839F9Q35326340-05E75F96-4555-482D-9A6C-9A8A8D1F1C5AQ35383033-357A97A6-E9D6-451A-824E-96C04EA0B272Q35599824-2B234031-E752-4CB8-8367-B8E7FD8AAD48Q35689047-645E4E89-5147-4F92-B7BE-362A92AF594EQ35945819-993DDB79-28FF-4BF5-9907-17F8258556B4Q36250298-12DC80FB-460B-4311-B263-B6A37AA6E640Q36263415-F482D79D-DFF7-416A-AD93-F4EA61958B8CQ36350140-6B1329B0-EEA5-469F-858F-E5440754FEFCQ36355432-2B231214-CE9B-4BE7-AD17-AE4C0B460496Q36415774-4FFFDB28-9FBD-45DA-9E68-C70C61339E62Q36505260-CF3A8833-87D0-486B-87A3-7F505E2026EDQ36951570-B05C13AC-9748-41A6-9D31-E7153EAB420DQ36965100-720D67B5-A7B1-4E63-BFD0-408EFCEE7835Q36967490-8D244CEB-CC70-433A-8899-537B15BC7F59Q36974789-A2A2B46F-5CD4-4EB8-A8E9-61CEB5169FF1Q36974898-3EF8E1AC-810F-4625-865C-B5BBF4ADCAD0Q36976977-5EABA5B2-E00F-4392-BE6C-778CC700DCEFQ36988356-69872A41-A417-475F-BAA0-9F00D0FF4FF4
P2860
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Molecular basis of Escherichia ...... model of human pyelonephritis.
@ast
Molecular basis of Escherichia ...... model of human pyelonephritis.
@en
Molecular basis of Escherichia ...... model of human pyelonephritis.
@nl
type
label
Molecular basis of Escherichia ...... model of human pyelonephritis.
@ast
Molecular basis of Escherichia ...... model of human pyelonephritis.
@en
Molecular basis of Escherichia ...... model of human pyelonephritis.
@nl
prefLabel
Molecular basis of Escherichia ...... model of human pyelonephritis.
@ast
Molecular basis of Escherichia ...... model of human pyelonephritis.
@en
Molecular basis of Escherichia ...... model of human pyelonephritis.
@nl
P2093
P2860
P356
P1476
Molecular basis of Escherichia ...... model of human pyelonephritis.
@en
P2093
P2860
P304
P356
10.1172/JCI111707
P407
P577
1985-02-01T00:00:00Z